Letrozole
Active substance: letrozole
TABLET, FILM COATED · LETROZOLE 2.5 mg/1
United StatesActive
Marketing holder: Yiling Pharmaceutical, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- LETROZOLE · 2.5 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-46e2-720f-a521-760243dabf99,01a1208c-59b2-7b1a-af73-f0c0a53de7b7,01a1208c-6af7-79ff-b873-a3a81e5a2bfe,01a1208d-6f17-735f-b40f-d8d98b2fc8f4,01a1208d-854a-7e7f-8ce8-0cde2d7f3092;count=25 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 69117-0004
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 69117-0004 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 69117-0004 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 69117-0004 · Verified 2026-10-09 · open in source